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 Breast cancer is the cancer with the largest prevalence, both in Poland and worldwide. The standard treatment in patients 
with this disease is breast-conserving therapy (BCT), followed by whole breast radiotherapy (WBRT) with a boost dose 
applied to the area of the bed created after tumour resection. In women who have undergone breast amputation – in 
the presence of poor prognostic factors – the chest wall is irradiated with or without the irradiation of the axillary fossa 
and clavicular area. Radiotherapy is used as an adjuvant treatment in connection with the high rate of relapses in the area 
of the treated breast – as much as 20% after 10 years. Some patients, before the commencement of the irradiation, are 
treated systemically with the use of regimens comprising drugs with a high degree of cardiotoxicity. This effect may even 
be increased during the course of radiotherapy – mainly in patients after amputation of the left breast. The side-effects 
induced by radiotherapy depend on area of the heart within the field of irradiation. Studies suggest that the vulnerable 
parts of the heart are the coronary vessels, and primarily, the left anterior descending (LAD) artery, which is located close 
to the chest wall.
 The objective of this study is to present practical guidelines concerning contouring the left anterior descending (LAD) 
artery in patients with cancer of the left breast, who have qualified for radiotherapy.
 Contouring the LAD seems to be significant as a method of assessing the critical organ during radiotherapy. The results 
may cause a modification of the treatment strategy: a change to  the planned radiotherapy, the quantity of the beams  
and/or their angle of incidence or a change in the beam weight.
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Introduction
Breast cancer is the most frequently occurring type of cancer, 
both in Poland and worldwide [1]. The standard treatment in 
patients with this disease is the breast-conserving therapy 
(BCT), followed by whole breast radiotherapy (WBRT) with 
a  boost dose applied to the area of the bed created after 
tumour resection. In women who have undergone breast 
amputation – in the presence of poor prognostic factors – 
the chest wall is irradiated with or without the irradiation of 
the axillary fossa and clavicular area. Radiotherapy is used as 
an adjuvant treatment in connection with the high rate of 
relapse in the area of the treated breast – as much as 20 % 
after 10 years [1, 2]. 
Some patients, before the commencement of the irra-
diation, are treated systemically with the use of the regimens 
comprising drugs with a high degree of cardiotoxicity. This 
effect may even be increased during the course of radiothe-
rapy – mainly in patients after amputation of the left breast. 
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The objective of the study 
The objective of the study is to present practical guidelines 
concerning contouring the left anterior descending (LAD) 
artery in patients with the cancer of the left breast,  who have 
qualified for radiotherapy.
Materials and methods  
50 patients treated in the Radiotherapy Department of the 
Oncology Centre in Bydgoszcz were qualified to the study. 
All the patients had breast cancer and had been surgically 
treated: in 14 of them a breast had been amputated, and in 
36 of them BCT (breast conserving therapy) had been applied. 
All the women had indications for adjuvant radiotherapy. After 
qualification for the treatment, a routine CT for radiotherapy 
planning was performed  (Tab. Ia, Ib, Ic).
CT was performed in patients in the lying position with 
limbs abducted and rotated with the use of a Posirest support. 
Before assessment, a tracer was applied on the entire length 
of the scar. The scans were made every 3 mm, during free and 
gentle breathing, whilst the images were sent to an Eclipse 
planning system with the use of a DICOM system. In each pa-
tient apart from the standard clinical target volume (CTV) and 
risk organs, LAD was contoured. One examiner identified the 
location of the LAD on the basis of the course of the anterior 
interventricular sulcus, whilst the other (in an independent 
manner) – controlled the LAD contouring.
In the patients who had undergone breast amputation, 
the area of clinical target volume (CTV) comprised the entire 
chest wall together with the resection bed, skin, muscles, deep 
fascia and ribs; with a margin of 0.5 cm to the planned target 
volume (PTV) and adaptation to the anatomic structures with 
a total dose of 45 Gy in 20 fractions. In the patients who had 
undergone BCT, the CTV area comprised the entire breast and 
the tumour resection bed, sparing the lower lying muscles, ribs 
and skin; with a margin of 0.5 cm to PTV and adaptation to the 
anatomic structures with a total dose of 42.5 Gy in 17 fractions. 
In some patients a boost was carried out with brachytherapy, 
at a dose of 10 Gy in 1 fraction, whist in the remaining patients 
– with the use of and external beam at a total dose of 10–12 
Gy in 4–6 fractions, with 2–2.5 Gy per fraction. 
In radiotherapy planning, most frequently, 2 tangential 
fields with adaptation of the posterior border were applied, 
with the use of mechanical and/or dynamic wedges of 15–30 
degrees and photon radiation with the energy of 6 and 15 MeV. 
In the majority of patients who had undergone mastectomy, 
a tissue-like bolus was required, whilst some patients who 
had undergone BCT needed a strip of tissue-like bolus in the 
midline.
Results
After analysis of the contouring of LAD in 50 patients by 2 in-
dependent examiners and after comparison of their drawings, 
the following conclusions were drawn:
1. The LAD is invisible in some places and its location should 
be interpolated from the previous scans.
2. The LAD is best visible in women with coronary athero-
sclerosis.
3. Coronary vessels are best visible for contouring in the 
windows from +600 to 800 and –150 to –200 Hausfield 
units (HU).
4. The easiest way to identify the LAD is to begin with the 
upper part of the heart, where this artery is located be-
tween the left and right heart ventricle and to right of 
the descending aorta – i.e. in the place where the LAD 
Table Ia. Mean maximum dose (Dmax), mean minimum dose (Dmin), mean average dose  (Dmean ) and mean median dose (Dmed) for the heart and LAD 
in all patients
Dmax (Gy) Dmin (Gy) Dmean  (Gy) Dmed (Gy)
Heart 42.10 0.57 5.08 1. 87
LAD 41.46 3.21 30.03 32.22
Table Ib. Mean maximum dose (Dmax), mean minimum dose (Dmin), mean average dose  (Dmean ) and mean median dose (Dmed) for the heart and LAD 
for the patients who had undergone BCT
Dmax (Gy) Dmin (Gy) Dmean  (Gy) Dmed (Gy)
Heart 42.62 0.58 5.96 2.34
LAD 40.94 3.91 32.11 35.45
Table Ic. Mean maximum dose (Dmax), mean minimum dose (Dmin), mean average dose  (Dmean ) and mean median dose  (Dmed) for the heart and LAD 
for the patients who had undergone mastectomy
Dmax (Gy) Dmin (Gy) Dmean  (Gy) Dmed (Gy)
Heart 41.39 0.42 5.45 1.48
LAD 41.31 3.46 31.05 32.63
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branches away from the main left coronary artery, and then 
runs towards the front and down towards the heart apex.
5. There were significant differences observed between 
specific CT scans with regards to the location of the LAD, 
which were connected to its tortuous course, and which 
led to significant difficulties in interpolating its location 
on the next scans.
6. The vessel is so small near the heart apex that it is rarely 
visible.
7. In about 1/3 of the upper part of the heart LAD is poorly 
visible; the anterior interventricular sulcus must be located 
as the artery runs in this area.
8. During contouring, it was observed that the LAD in 1/2 or 
1/3 of the heart length is adjacent to the chest wall from 
the inside (this concerned the majority of the patients).
9. The area in which the LAD was adjacent to the chest wall 
was largest in women with heart disease and the vessel 
did not have a circular cross-section,
10. In the group of young and very slim patients, there were 
cases in which the LAD and the entire heart were not 
adjacent to the chest wall so the dose applied to these 
structures was minimal and, moreover, the cross-section 
of vessel in these patients was circular, which significantly 
facilitated its identification.
11.  In patients with a lower body mass index, a thinner chest 
wall and/or a small amount of fatty tissue in the pericardi-
um, the dose per LAD was higher than in patients with a 
larger amount of the pericardial fatty tissue, which isolated 
the LAD from the chest wall, thus increasing the distance 
between them.
12. A comparison of the contouring of the left anterior de-
scending (LAD) artery made by two independent exam-
iners did not reveal any significant differences, and these 
differences decreased even more with an increase in the 
experience in locating the vessel and in precision in con-
touring,
13. When, in accordance with the suggestions of other au-
thors, a 1 cm margin was added around the vessel with 
regard to difficulties in contouring and the respiratory 
mobility of the heart, all the patients then had the LAD 
located in this area, irrespective of the person who per-
formed the contouring of the risk organ; and when the 
examiners had more experience in contouring, a margin 
of 0.5 cm was sufficient.
Discussion 
Clinical studies carried out among patients with breast cancer 
point to the benefits in adjuvant radiotherapy, after both BCT 
and breast amputation, where the risk of recurrence is high. 
The side-effect connected with radiotherapy is an increase 
in cardiological incidents, which might lead to death [3–5]. 
Irradiation may cause 2 types of cardiovascular disease: 
micro- and macrovascular diseases. The first group is charac-
terised with a decrease in the density of the vessels within the 
heart leading to chronic heart ischemic disease and myocardial 
infraction secondary to focal degeneration. In macrovascular 
diseases, in turn, irradiation accelerates and/or intensifies the 
development of coronary atherosclerosis [6]. 
Currently, many strategies are applied in order to minimize 
the effects of systemic treatment and/or radiotherapy. Modern 
methods of reducing cardiotoxicity comprise radiotherapy 
planning techniques: the use of coplanar beams, megavolt 
energy, intensity-modulated radiotherapy (IMRT), deep inspi-
ration breath hold (DIBH), spiral tomotherapy or irradiation 
with the use of special immobilisation used when a patient 
is in the prone position – for women after breast conserving 
surgery [2, 6].
Retrospective studies carried out among women with 
breast cancer showed a significant effect of irradiation on the 
heart and, consequently, an increase in the cardiotoxicity of this 
type of treatment; some correlation was observed between 
the mortality rate and the dose-volume histogram (DVH) in 
this critical organ, namely the heart [3–5].
Radiotherapy-induced adverse effects depend on the re-
gion of the heart which is contained in the field of irradiation. 
Studies suggest that these important areas are made up of the 
coronary vessels, and, primarily the LAD, which is located in 
close proximity to the chest wall. The  LAD contouring seems, 
therefore, significant for the assessment of the critical organ 
during radiotherapy. The results of contouring may influence 
the modification of the treatment strategy: a change of the 
technique of the planned radiotherapy, the quantity of the 
beams and/or their angle of incidence or a change of the 
beam weight [7, 8].
The results of many clinical studies suggest that patients 
with cancer of the left breast are exposed to a larger risk of 
cardiovascular complications than those with cancer located 
in the right breast [2, 4, 5]. Tanaka states that in patients with 
breast cancer receiving radiotherapy, the mortality rate con-
nected with heart disease was between 1.27 and 1.76 times 
higher than in patients without radiotherapy  [9]. Borger et al. 
estimated that for patients with left breast cancer who rece-
ived radiotherapy with the use of tangential fields, the rate of 
cardiological complications was 1.38 (95% confidence interval: 
1.09–2.15) in comparison with a location in the right breast [10]. 
It must also be remembered that patients with breast 
cancer make up a group in whom radiotherapy planning is 
very difficult – in particular in women after mastectomy, in 
whom the chest wall thickness is very low, which increases the 
quantity of the irradiation deposited in soft tissue. This leads 
to the fact that a larger dose is administered to the lung and/
or heart parenchyma, and that dose is also administered onto 
a larger area [2]. Studies clearly show that each dose increase 
by 1 Gy for the heart, results in an increase of mortality rate 
by 3% within 20 years [2]. In patients with chest wall radio-
therapy, asymptomatic disorders of the perfusion of the heart 
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vessels, occurring within 6 to 24 months of the completion of 
radiotherapy are observed [11, 12]. There are some individual 
reports which exclude the effect of radiation dose on the heart, 
yet these reports were published in the last century, where 
treatment planning and realisation were completely different 
so now it is difficult to make any reference to these reports [2].
The largest difficulty in contouring the LAD is the fact that in 
the majority of centres no contrast agent is administered for the 
CT when planning radiotherapy. This significantly deteriorates 
the visibility of the course of the vessel, in particular given the 
fact that this artery is very small and has a tortuous course, and 
its diameter is usually 3 mm (and at the apex – about 1 mm) [13]. 
Venarini et al. used computed tomography with optimum 
image resolution obtained thanks to a detector measuring 0.5 
mm, yet the patients’ breath and the kinetics of circulation 
led to blurring of the image, which made imaging of the 
LAD very difficult [13]. During the contouring process it was 
observed that the left anterior descending artery, in 1/2 or 
1/3 of its length, is most frequently adjacent to the chest wall 
from inside. In this very place, the LAD is also located close to 
the sternum, and, because of this location and the necessity 
of irradiating the whole chest wall in patients who have un-
dergone breast amputation, when adding a margin to clinical 
target volume (CTV), the LAD lies within the planned target 
volume (PTV). This allowed the clinicians to draw conclusions 
and introduce corrections while contouring and treatment 
planning. Much more attention was paid to the correctness 
of the LAD contouring and target volumes so that the part 
of the artery within the field of the therapeutic beam could 
be limited and/or the creation of “hot spots” i.e. areas of high 
dose could be reduced. 
Venarini et al. assessed the location of the left anterior 
descending artery in 25 breast cancer  patients and presented 
practical guidelines for contouring this structure. They empha-
sised that the location of the LAD is, in some places, invisible, 
and therefore must be interpolated from previous scans, whe-
reas the visibility of the vessel is  also negatively affected by 
artefacts created by breathing and the heartbeat [13]. 
Jagsi et al. [14] in turn, evaluated the size of the relocation 
of the left anterior descending artery in a group of 10 patients 
and observed that the largest movements of the LAD occur 
in the vertical (up and down) plane. At the same time, they 
stressed that a good visualisation and the possibility of conto-
uring allowed for the exclusion of the LAD from the irradiated 
volume. Venarini et al. in their study, specified the doses for 
critical organs, and found that the observance of these doses 
may have some influence on the protection of those organs. 
They calculated the maximum admissible dose for the LAD, 
being for D2% from 2.7 to 41.7 Gy, and V 25 Gy for the heart 
should be lower than 6%, and most frequently it was 1.5% with 
standard deviation being +/–2.1% [13]. 
Di Franco et al. [6] pointed to difficulties in LAD contouring, 
observing, at the same time, that with regards to the difficulties 
in contouring and the respiratory mobility of the heart, a 1 cm 
margin should be added around the vessel [6]. In our opinion, 
a 0.5 cm margin is sufficient around the LAD, provided that the 
examiner has gained practical skills in contouring. Certainly, in 
patients with large respiratory mobility of the heart and with 
difficulties in vessel visualisation, adding a 1 cm margin might 
turn out to be necessary.
 In the case of patients with a burden of cardiological 
comorbidities, a selection of other radiotherapy planning and 
realisation techniques must be taken into consideration. The 
DIBH technique is one of the ways of minimising the dose of 
radiation for the heart and coronary vessels [15–18]. Thanks to 
this technique the Dmax and Dmean for the LAD decrease by 
approximately 50–60%. This is a very useful form of therapy, 
but also very time consuming and the capacity is lower as well. 
Moreover, this form of therapy forces a patient to maintain 
strict cooperation during the entire treatment process, which 
is sometimes difficult or even impossible.   
Blank et al. [19] reported that the time span between ente-
ring the apparatus and administering the first fraction of treat-
ment with slow breathing was, on average, 42 minutes, whilst 
the time span of conventional treatment was 15 minutes [19].
Our observations show that in patients with a larger quan-
tity of fatty tissue and a thicker chest wall, the dose deposited 
on the LAD area was lower than in the case of persons with 
a thin chest wall and/or smaller amount of the fatty tissue. 
Similar observations were made by  Tanaka et al. [9]. In patients 
with a lower body mass index, a thinner chest wall and a small 
amount of fatty tissue in the pericardium, the irradiation dose 
for the LAD was higher than in patients with larger amounts of 
pericardial fatty tissue which isolated the LAD from the chest 
wall, increasing the distance between them. In multivariant 
analysis, BMI was significantly correlated with Dmax, V 20 Gy 
and V 30 Gy. In patients with BMI ≤22 kg/m2 and with BMI 
>22 kg/m2 there were significant differences in the Dmean 
and V 40 Gy doses[9].
In the study of Niedere et al. [20] the average LAD volume 
was 1.94 cm (1.28–2.86). Planning was carried out with the use of 
3D and IMRT techniques. As in some patients, PTV was very close 
to the LAD, it was not possible to reduce the dose of irradiation 
there. In the case of planning with the use of the IMRT technique, 
the deposited radiation was much lower in comparison with the 
3D technique. And thus, in the case of a small LAD volume, 100% 
of the vessel received the prescribed dose, and with the IMRT 
technique the reduction of the mean dose was 44%. Maximum 
accepted doses and volumes for the LAD, adopted by the authors 
of the study were: a maximum 60% dose for any LAD volume, a 
20% dose for 75% LAD volume, a 40% dose for 50% LAD volume 
and a 50% dose for 20% LAD volume [20].
Conclusions 
The contouring of the left anterior descending artery is always 
difficult, but may reduce the post-radiation side effects, and 
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therefore may allow for a lower rate of cardiological incidents. 
Thanks to this process, the treatment planning and execution 
may be modified on the basis of the LAD location. However, 
further prospective studies carried out on larger groups of 
patients are necessary.
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